Here are relevant reports on : marine-biotechnology-market
-
Gel Documentation Systems Market by Product (Instruments (Digital), Software), Light Source (Laser, LED, UV), Detection (Chemiluminescence), Application (Nucleic Acid), End User (Academic Institutes, Biotechnology Companies) & Region - Global Forecast to 2023
The gel documentation systems market is projected to reach USD 304 million by 2023, at a CAGR of 3.3%. Growth in the gel documentation systems market is mainly driven by the increasing prevalence of infectious and chronic disease, and rising research & development expenditure in the pharmaceutical and biotechnology companies. The major players in the gel documentation systems market are GE Healthcare (US), Bio-Rad Laboratories, inc. (US), Thermo Fisher Scientific (US), LI-COR Biosciences (US), Endress+Hauser Management AG (Switzerland), Vilber Lourmat (France), Scientific Digital Imaging plc (UK), Bio-Techne (US), Cleaver Scientific (US), and Azure Biosystems (US).
- Published: December 2018
- Price: $ 4950
- TOC Available:
-
Bioburden Testing Market by Product (Consumables, Instrument (PCR, Microscope)), Test (Anerobic, Mold/Fungi, Aerobic, Spore), Application (Raw Material, Medical Devices, Sterility Testing), End User (Pharma, Biotechnology, CMO) - Global Forecast to 2023
The bioburden testing market is projected to reach USD 1,103 million by 2023 from USD 614 million in 2018, at a CAGR of 12.4% during the forecast period. Growth in this market can be attributed to factors such as the growth in the medical devices, pharmaceutical, and biotechnology industries; rising safety concerns related to food and beverage products; and the increasing number of product recalls due to microbial contamination. However, the high cost of enumeration instruments is expected to restrain market growth in the coming years. The bioburden testing market is competitive in nature, with the presence of several large and small players. Charles River (US), Merck KGaA (Germany), SGS SA (Switzerland), WuXi AppTec (China), Becton, Dickinson and Company (US), NAMSA (US), Nelson Laboratories, LLC (US), Thermo Fisher Scientific (US), biomérieux SA (France), and Pacific BioLabs (US) are some of the leading payers in the bioburden testing market.
- Published: December 2018
- Price: $ 4950
- TOC Available:
-
EDS, WDS, EBSD, Micro-XRF Instruments Market by Product, by Application (Energy, Defense, Metals, Medical, Research, Agriculture, Nanotechnology, Electronics, Biotechnology, Automotive, Pharmaceutical, Oil and Gas) - Global Forecasts to 2019
The global EDS, WDS, EBSD, and Micro-XRF instruments market is segmented on the basis of products, applications, and regions. Based on products, the market is categorized into EDS, WDS, EBSD, and Micro-XRF. The EDS segment accounted for a major share of the market, by product, in 2014. The global EDS, WDS, EBSD, and Micro-XRF instruments market is expected to reach USD 1,529.6 Million by 2019 from USD 403.6 Million in 2014, at a CAGR of 5.6% during the forecast period.
- Published: October 2015
- Price: $ 4950
- TOC Available:
-
PEGylated Proteins Market by Consumables (PEGylation Kits, Reagents), Services, Protein Type (mAbs, Interferons), Application (Cancer Treatment, Chronic Kidney Diseases), End-User (Pharmaceutical & Biotechnology Companies)- Global Forecast to 2021
The global PEGylated proteins market size is projected to grow at a CAGR of 10.5%. The major drivers for the market include increase in R&D spending of pharmaceutical & biotechnology companies, growth in biologics sector, high prevalence of lifestyle disease, increasing focus on strategies to improve protein stability and circulating half-life. The rising opportunities in emerging markets and top-selling biologics drugs going off-patent in the near future will provide new growth opportunities for this market.
- Published: November 2016
- Price: $ 4950
- TOC Available:
-
Specialty Enzymes Market by Source (Microorganism, Plant, Animal), Type (Carbohydrases, Proteases, Lipases, Polymerases & Nucleases), Application (Pharmaceuticals, Diagnostics, Research & Biotechnology), Form & Region - Global Forecast to 2029
According to MarketsandMarkets, the global Specialty enzymes market size is projected to reach USD 9.2 billion by 2029, recording a CAGR of 8.5% during the forecast period. Key players in this market include BRAIN Biotech AG (Germany), Novozymes A/S (Denmark), Codexis, Inc. (US), Sanofi (France), Merck KGaA (Germany), Dyadic International Inc (US), Advanced Enzyme Technologies (India), Amano Enzyme Inc (Japan), F. Hoffmann-La Roche Ltd (Switzerland), New England Biolabs (US), BBI Solutions (UK), Creative Enzymes (US), Bioseutica (Netherland), and SEKISUI Diagnostics (US)
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Chromatography Resin Market by Type (Natural, Synthetic, Inorganic Media), Technique ((Ion Exchange (Cation and Anion), Affinity (Hydrophobic Interaction, Mixed Mode)), Application (Pharmaceutical & Biotechnology), and Region - Global Forecast to 2030
The chromatography resin market size was USD 3.02 billion in 2024 and is projected to reach USD 4.94 billion by 2030, at a CAGR of 8.6%, between 2025 and 2030. The key players profiled in the report include Bio-Rad Laboratories, Inc. (US), Merck KgaA (Germany), Danaher Corporation (US), Tosoh Corporation (Japan), Sartorius Stedim Biotech S.A. (France), Bio-Works Technologies AB (Sweden), Avantor, Inc. (US), Purolite (US), Repligen Corporation (US), Mitsubishi Chemical Group Corporation (Japan), and Thermo Fisher Scientific Inc. (US), among others.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Aptamers Market by Product Type (DNA, RNA, XNA), Technology (SELEX), Application (Therapeutics, Diagnostics, R&D), End Users (Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes, CROs) - Global Forecast to 2026
The global aptamers market growth is primed to transition from $151 million in 2021 to $342 million by 2026, showcasing a strong CAGR of 17.7%. Growth of the market is attributed to factors such as increase in number of clinical trials for development of aptamer-based therapeutics, increase in awareness about advantages of aptamers as compared to antibodies, rising investment in pharmaceutical R&D, and rising prevalence of chronic and rare diseases to increase the demand for aptamer-based therapeutics and diagnostics. Growth in the venture capital funding for research on aptamers and growing collaborations with research institutes and pharmaceutical companies are also expected to offer a wide range of growth opportunities to players in the market.
- Published: November 2021
- Price: $ 4950
- TOC Available:
-
Pipette Calibrators Market by Type (Devices, Software), Channel Type, Method (Gravimetry, Photometry), Application (Research (Drug Discovery), Clinical Diagnostics), End User (Pharmaceutical & Biotechnology), & Region - Global Forecast to 2029
The global pipette calibrators market, valued at US$255 million in 2022, stood at US$286 million in 2023 and is projected to advance at a resilient CAGR of 6.5% from 2023 to 2028, culminating in a forecasted valuation of US$391 million by the end of the period. The growth in this market is attributed to the increasing need for pipettes in research facilities, and growing use of portable handheld calibration devices, and adoption of cloud-based calibration management. However, presence of alternative simple methods or techniques could restrain the growth of this market.
- Published: February 2024
- Price: $ 4950
- TOC Available:
-
Laboratory Balances and Scales Market by Product (Balances (Analytical, Precision, Micro, Portable, Moisture), Scales (Bench, Counting, Compact)), End User (Pharmaceutical, Biotechnology, Chemical, Beverage, Petroleum, Academia) - Global Forecasts to 2023
The Laboratory Balances and Scales Market is projected to reach USD 1.6 billion by 2023, growing at a CAGR of 3.7%. Growth in the lab balances and scales market is primarily driven by factors such as technological advancements in laboratory balances and scales; expansion of research pipeline among pharma-biotech and CROs; increasingly stringent regulatory framework for product safety in biotechnology and pharmaceutical industries; and growing public emphasis on Implementation of stringent food safety guidelines. The major players operating in the lab balances and scales market are A&D Company, Ltd (Japan), Metler Toledo international, Inc. (US), Sartorius AG (Germany), Shimadzu Corporation (Japan), PCE Instruments (UK), Kern & Sohn GmbH (Germany), RADWAG Balances and Scales (Poland), Adam Equipment Co. (UK), Avery Weigh-Tronix, LLC (UK), Bonso Electronics International, Inc. (China), Essae Group (India), and Gram Precision S.L (Spain).
- Published: November 2018
- Price: $ 4950
- TOC Available:
-
Atomic Spectroscopy Market by Technology (Atomic Absorption Spectroscopy/X-Ray Fluorescence/X-Ray Diffraction/ICP-MS/ICP-OES) & by Application (Food & Beverage Testing/Pharmaceuticals & Biotechnology / Environmental Testing) - Analysis & Global Forecast to 2020
The atomic spectroscopy market is poised to reach USD 5.60 Billion by 2020, growing at a CAGR of 6.0% during the forecast period of 2015 to 2020. The growth of the overall atomic spectroscopy market can be contributed to rising investments, funds, and grants by government bodies worldwide and technological advancements. In addition, growing food safety concerns and stringent regulations have contributed to market growth.
- Published: January 2016
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
